About Madrigal:
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was granted accelerated approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults with NASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) and is being studied in a Phase 3 trial for the treatment of NASH with compensated cirrhosis.
Role Overview:
Access and Reimbursement Manager
We are seeking dedicated and results-driven Access and Reimbursement Managers (ARMs) to join our team. In this role, you will serve as the primary field-based resource to support practices in ensuring optimal patient access to a large pharmacy benefit specialty product. You will collaborate closely with healthcare providers and internal teams to address access barriers, deliver patient-centric solutions, and educate stakeholders on reimbursement processes.
Position Responsibilities:
- Patient Access Support:
- Work directly with HCP offices to provide expertise on access and reimbursement challenges, including benefits investigation, prior authorizations, appeals, and financial assistance.
- Partner with healthcare providers to ensure patients have timely access to prescribed therapy by addressing access issues proactively.
- Education and Training:
- Educate healthcare providers and their staff on payer-specific policies, coverage criteria, and reimbursement processes for the specialty product.
- Conduct in-service programs and provide resources to help practices navigate access challenges effectively.
- Collaboration with Internal Teams:
- Act as a liaison between the field team and internal stakeholders, providing insights on regional access trends and challenges.
- Collaborate with trade, market access, sales, patient support services, and analytics teams to ensure alignment and support for practices.
- Problem Solving and Escalation:
- Identify and resolve access barriers through collaboration with payers, specialty pharmacies (SPs), and other key stakeholders.
- Escalate unresolved issues to appropriate teams, ensuring timely resolution and communication back to providers.
- Data-Driven Execution:
- Leverage data and analytics tools to identify access trends, prioritize efforts, and report progress to leadership.
- Maintain accurate records of activities and interactions with practices to ensure compliance and track outcomes.
Qualifications and Skills Required:
- Bachelor’s degree required; advanced degree or certification in healthcare-related fields is a plus.
- Minimum of 5 years of experience in access and reimbursement, patient support services, or pharmaceutical field roles.
- Knowledge of pharmacy benefit structures, reimbursement processes, and specialty pharmacy networks.
- Experience in Hepatology, Gastroenterology, Endocrinology is preferred
- Strong interpersonal and communication skills, with the ability to build relationships and provide exceptional customer service.
- Proven ability to work independently, prioritize tasks, and adapt to a fast-paced environment.
- 40-50% Travel required within the assigned territory.
Key Competencies:
- Expertise in access and reimbursement, including payer policies and processes.
- Strong presentation and training skills, with the ability to explain complex concepts in a clear and concise manner.
- Problem-solving mindset with a focus on delivering practical solutions.
- Ability to collaborate effectively with cross-functional teams and external stakeholders.
Compensation
The expected annual base salary range for this role is between $170,000 – $220,000. Base salary is determined by several factors that include, but are not limited to, a successful candidate's qualifications, skills, education, experience, business needs, and market demands. The role may also be eligible for bonus, equity, and comprehensive benefits, which include flexible paid time off (PTO), medical, dental, vision, and life and disability insurance.
What We Do
Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a clinical-stage biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), a liver disease with high unmet medical need. Madrigal’s lead candidate, resmetirom, is a once daily, oral, thyroid hormone receptor (THR)-β selective agonist that is designed to target key underlying causes of NASH in the liver. Resmetirom is currently being evaluated in two Phase 3 clinical studies, MAESTRO-NASH and MAESTRO-NAFLD-1, designed to demonstrate multiple benefits in patients with NASH. For more information, visit www.madrigalpharma.com